Parallax Volatility Advisers
CLOV icon

Parallax Volatility Advisers’s Clover Health Investments CLOV Stock Holding History

Parallax Volatility Advisers’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-400
Closed -$381 – 1897
2023
Q4 		$381 Hold
400
– – ﹤0.01% 2105
2023
Q3 		$432 Sell
400
-244,400
-100% -$291K ﹤0.01% 2219
2023
Q2 		$220K Buy
244,800
+244,400
+61,100% +$217K ﹤0.01% 1873
2023
Q1 		$339 Sell
400
-400
-50% -$438 ﹤0.01% 2624
2022
Q4 		$744 Buy
+800
New +$1.07K ﹤0.01% 2759
2022
Q3 		– Sell
-1,200
Closed -$2K – 3090
2022
Q2 		$2K Sell
1,200
-1,771,800
-100% -$4.71M ﹤0.01% 2768
2022
Q1 		$6.29M Buy
+1,773,000
New +$5.14M ﹤0.01% 908
2021
Q4 		– Sell
-100,700
Closed -$744K – 3060
2021
Q3 		$744K Buy
100,700
+20,100
+25% +$172K ﹤0.01% 2100
2021
Q2 		$1.07M Buy
+80,600
New +$792K ﹤0.01% 1903

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Parallax Volatility Advisers's CLOV Position: Q1 2025 in Review

Parallax Volatility Advisers sold out of Clover Health Investments (CLOV) in Q1 2025, closing a stake of 19,855 shares — an estimated $62.5K sold.

Parallax Volatility Advisers first reported a position in CLOV in Q1 2021 and held it in 10 quarters. The position peaked at $185K in Q4 2021. 202 funds tracked by Wall St. Rank hold CLOV as of Q1 2025.

  • Parallax Volatility Advisers reported no remaining Clover Health Investments position as of Q1 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 19,855 Clover Health Investments shares in Q1 2025, an estimated $62.5K.
  • Parallax Volatility Advisers first reported a position in Clover Health Investments in Q1 2021 and held it in 10 quarters.
  • Parallax Volatility Advisers's Clover Health Investments position peaked at $185K in Q4 2021.
  • 202 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2025.

Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.